PeproStat Haemostat Study in Subjects Undergoing Liver Surgery
NCT02204930
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemorrhage
Interventions
DRUG:
PeproStat
Sponsor
Haemostatix Ltd